The authors thank Prof. C. J. L. M. Meijer for his continuous support. They are grateful to Mr. B. Bakker, Mrs. T. Tadema, Mrs. N. Fransen Daalmeijer, and Mrs. P. van Diemen for excellent technical assistance. Coated slides for liquid-based cytology were kindly provided by Ventana Medical Systems. S
A comparison of the clinical utility of p16INK4a immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia
β Scribed by Holladay, E. Blair ;Logan, Sarah ;Arnold, Jeffrey ;Knesel, Brad ;Smith, G. Denice
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 358 KB
- Volume
- 108
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The primary goal of this study was to compare the clinical performance of an optimized and rigorously controlled immunocytochemical (ICC) assay for p16^INK4a^ to highβrisk (HR) human papillomavirus (HPV) detection by polymerase chain reaction (PCR) as diagnostic adjuncts
Given the frequency and persistence of human papillomavirus (HPV) infection and associated cytological alterations in HIV-1-positive women, the incidence of uterine cervix neoplasm is likely to increase along with patient survival. More appropriate screening programs, which, in addition to Pap smear
## Background: Interlaboratory peer comparison programs are quality-assurance activities mandated by the clinical laboratory improvement amendments of 1988. no commercial program is available currently that was designed for cytology laboratories performing only human papillomavirus (hpv) dna testin
## Abstract To test the reliability of the Hybrid Capture II (HCβII) assay detecting 13 highβrisk human papillomavirus (HRβHPV) types for the screening of cervical lesions, we monitored by cytology, HRβHPV testing, colposcopy and biopsy, 3,091 women with normal smears at the first entry. Our primar